Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 4048235, 17 pages
http://dx.doi.org/10.1155/2016/4048235
Research Article

Low Dose BCG Infection as a Model for Macrophage Activation Maintaining Cell Viability

1Department of Pathology and Immunology, Centre Medical Universitaire (CMU), Faculty of Medicine, University of Geneva, Geneva, Switzerland
2Laboratory of Integrative Immunology, National Institute of Respiratory Diseases “Ismael Cosio Villegas”, Mexico City, Mexico
3Department of Cell Physiology and Metabolism, Centre Medical Universitaire (CMU), Faculty of Medicine, University of Geneva, Geneva, Switzerland

Received 18 May 2016; Revised 26 August 2016; Accepted 15 September 2016

Academic Editor: Ethan M. Shevach

Copyright © 2016 Leslie Chávez-Galán et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Getahun, C. Gunneberg, R. Granich, and P. Nunn, “HIV infection-associated tuberculosis: the epidemiology and the response,” Clinical Infectious Diseases, vol. 50, no. 3, pp. S201–S207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Zumla, A. George, V. Sharma, R. H. N. Herbert, A. Oxley, and M. Oliver, “The WHO 2014 Global tuberculosis report-further to go,” The Lancet Global Health, vol. 3, no. 1, pp. e10–e12, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. King and W. H. Park, “Effect of Calmette's BCG vaccine on experimental animals,” American Journal of Public Health and the Nations Health, vol. 19, no. 2, pp. 179–192, 1929. View at Publisher · View at Google Scholar
  4. G. G. Mahairas, P. J. Sabo, M. J. Hickey, D. C. Singh, and C. K. Stover, “Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis,” Journal of Bacteriology, vol. 178, no. 5, pp. 1274–1282, 1996. View at Google Scholar · View at Scopus
  5. T. Hsu, S. M. Hingley-Wilson, B. Chen et al., “The primary mechanism of attenuation of bacillus Calmette-Guérin is a loss of secreted lytic function required for invasion of lung interstitial tissue,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 21, pp. 12420–12425, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. M. R. R. Lagranderie, A.-M. Balazuc, E. Deriaud, C. D. Leclerc, and M. Gheorghiu, “Comparison of immune responses of mice immunized with five different mycobacterium bovis BCG vaccine strains,” Infection and Immunity, vol. 64, no. 1, pp. 1–9, 1996. View at Google Scholar · View at Scopus
  7. B. Wu, C. Huang, L. Garcia et al., “Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guérin,” Infection and Immunity, vol. 75, no. 7, pp. 3658–3664, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Gernez Rieux and M. Gervois, “Protection conferred by BCG during the 20 years following vaccination,” Bulletin of the World Health Organization, vol. 48, no. 2, pp. 139–154, 1973. View at Google Scholar · View at Scopus
  9. C. A. Rentsch, F. D. Birkhäuser, C. Biot et al., “Bacillus calmette-guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy,” European Urology, vol. 66, no. 4, pp. 677–688, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Decobert, H. LaRue, F. Harel, F. Meyer, Y. Fradet, and L. Lacombe, “Maintenance bacillus Calmette-Guérin in high-risk nonmuscle-invasive bladder cancer: how much is enough?” Cancer, vol. 113, no. 4, pp. 710–716, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Olakanmi, L. S. Schlesinger, A. Ahmed, and B. E. Britigan, “The nature of extracellular iron influences iron acquisition by mycobacterium tuberculosis residing within human macrophages,” Infection and Immunity, vol. 72, no. 4, pp. 2022–2028, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. A. S. Davis, I. Vergne, S. S. Master, G. B. Kyei, J. Chua, and V. Deretic, “Mechanism of inducible nitric oxide synthase exclusion from mycobacterial phagosomes,” PLoS Pathogens, vol. 3, no. 12, article e186, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Dürrbaum-Landmann, J. Gercken, H.-D. Flad, and M. Ernst, “Effect of in vitro infection of human monocytes with low numbers of Mycobacterium tuberculosis bacteria on monocyte apoptosis,” Infection and Immunity, vol. 64, no. 12, pp. 5384–5389, 1996. View at Google Scholar · View at Scopus
  14. J. Keane, H. G. Remold, and H. Kornfeld, “Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages,” Journal of Immunology, vol. 164, no. 4, pp. 2016–2020, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Loeuillet, F. Martinon, C. Perez, M. Munoz, M. Thome, and P. R. Meylan, “Mycobacterium tuberculosis subverts innate immunity to evade specific effectors,” Journal of Immunology, vol. 177, no. 9, pp. 6245–6255, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Klingler, K.-M. Tchou-Wong, O. Brändli et al., “Effects of mycobacteria on regulation of apoptosis in mononuclear phagocytes,” Infection and Immunity, vol. 65, no. 12, pp. 5272–5278, 1997. View at Google Scholar · View at Scopus
  17. M. B. Santucci, M. Amicosante, R. Cicconi et al., “Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages: early membrane modifications and intracellular mycobacterial viability,” Journal of Infectious Diseases, vol. 181, no. 4, pp. 1506–1509, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Placido, G. Mancino, A. Amendola et al., “Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection,” Journal of Pathology, vol. 181, no. 1, pp. 31–38, 1997. View at Google Scholar · View at Scopus
  19. R. E. Butler, P. Brodin, J. Jang et al., “The balance of apoptotic and necrotic cell death in Mycobacterium tuberculosis infected macrophages is not dependent on bacterial virulence,” PLoS ONE, vol. 7, no. 10, Article ID e47573, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Wu, G. Deng, X. Hao et al., “A caspase-dependent pathway is involved in Wnt/β-catenin signaling promoted apoptosis in bacillus Calmette-Guerin infected RAW264.7 macrophages,” International Journal of Molecular Sciences, vol. 15, no. 3, pp. 5045–5062, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Palaga, S. Ratanabunyong, T. Pattarakankul et al., “Notch signaling regulates expression of Mcl-1 and apoptosis in PPD-treated macrophages,” Cellular and Molecular Immunology, vol. 10, no. 5, pp. 444–452, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Garcia, M. L. Olleros, V. F. J. Quesniaux et al., “Roles of soluble and membrane TNF and related ligands in mycobacterial infections: effects of selective and non-selective TNF inhibitors during infection,” Advances in Experimental Medicine and Biology, vol. 691, pp. 187–201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Engele, E. Stößel, K. Castiglione et al., “Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis,” Journal of Immunology, vol. 168, no. 3, pp. 1328–1337, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. L.-G. Bekker, S. Freeman, P. J. Murray, B. Ryffel, and G. Kaplan, “TNF-α controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways,” Journal of Immunology, vol. 166, no. 11, pp. 6728–6734, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. G. S. Dean, S. G. Rhodes, M. Coad et al., “Minimum infective dose of Mycobacterium bovis in cattle,” Infection and Immunity, vol. 73, no. 10, pp. 6467–6471, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. M. L. Olleros, R. Guler, N. Corazza et al., “Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guérin infection in the absence of secreted TNF and lymphotoxin-α,” Journal of Immunology, vol. 168, no. 7, pp. 3394–3401, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Dhandayuthapani, L. E. Via, C. A. Thomas, P. M. Horowitz, D. Deretic, and V. Deretic, “Green fluorescent protein as a marker for gene expression and cell biology of mycobacterial interactions with macrophages,” Molecular Microbiology, vol. 17, no. 5, pp. 901–912, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Guler, M. L. Olleros, D. Vesin et al., “Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins,” Journal of Hepatology, vol. 41, no. 5, pp. 773–781, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Z. Murray, J. G. Kay, D. G. Sangermani, and J. L. Stow, “Cell biology: A role for the phagosome in cytokine secretion,” Science, vol. 310, no. 5753, pp. 1492–1495, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Castaño, L. F. García, and M. Rojas, “Increased frequency and cell death of CD16+ monocytes with Mycobacterium tuberculosis infection,” Tuberculosis, vol. 91, no. 5, pp. 348–360, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Chávez-Galán, M. L. Olleros, D. Vesin, and I. Garcia, “Much more than M1 and M2 macrophages, there are also CD169+ and TCR+ macrophages,” Frontiers in Immunology, vol. 6, article 263, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. M. L. Olleros, D. Vesin, R. Bisig et al., “Membrane-bound TNF induces protective immune responses to M. bovis BCG infection: regulation of memtnf and TNF receptors comparing two memTNF molecules,” PLoS ONE, vol. 7, no. 5, article e31469, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. M. D. Turner, B. Nedjai, T. Hurst, and D. J. Pennington, “Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1843, no. 11, pp. 2563–2582, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. M. R. Gwinn and V. Vallyathan, “Respiratory burst: role in signal transduction in alveolar macrophages,” Journal of Toxicology and Environmental Health Part B: Critical Reviews, vol. 9, no. 1, pp. 27–39, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Torres and H. J. Forman, “Activation of several MAP kinases upon stimulation of rat alveolar macrophages: role of the NADPH oxidase,” Archives of Biochemistry and Biophysics, vol. 366, no. 2, pp. 231–239, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Gotoh and J. A. Cooper, “Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-α signal transduction,” Journal of Biological Chemistry, vol. 273, no. 28, pp. 17477–17482, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Jung, M.-K. Shin, Y.-K. Jung, and H. S. Yoo, “Modulation of macrophage activities in proliferation, lysosome, and phagosome by the nonspecific immunostimulator, mica,” PLoS ONE, vol. 10, no. 2, Article ID e0117838, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Garcia, R. Guler, D. Vesin et al., “Lethal Mycobacterium bovis Bacillus Calmette Guerin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2,” Laboratory Investigation, vol. 80, no. 9, pp. 1385–1397, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Chen, H. Gan, and H. G. Remold, “A mechanism of virulence: Virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis,” Journal of Immunology, vol. 176, no. 6, pp. 3707–3716, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Jamwal, M. K. Midha, H. N. Verma, A. Basu, K. V. S. Rao, and V. Manivel, “Characterizing virulence-specific perturbations in the mitochondrial function of macrophages infected with Mycobacterium tuberculosis,” Scientific Reports, vol. 3, article 1328, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. M. G. Netea, J. Quintin, and J. W. M. Van Der Meer, “Trained immunity: a memory for innate host defense,” Cell Host and Microbe, vol. 9, no. 5, pp. 355–361, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Kleinnijenhuis, J. Quintin, F. Preijers et al., “Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 43, pp. 17537–17542, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Keane, M. K. Balcewicz-Sablinska, H. G. Remold et al., “Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis,” Infection and Immunity, vol. 65, no. 1, pp. 298–304, 1997. View at Google Scholar · View at Scopus
  44. C. J. Riendeau and H. Kornfeld, “THP-1 cell apoptosis in response to Mycobacterial infection,” Infection and Immunity, vol. 71, no. 1, pp. 254–259, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. D. M. Kelly, A. M. C. ten Bokum, S. M. O'Leary, M. P. O'Sullivan, and J. Keane, “Bystander macrophage apoptosis after Mycobacterium tuberculosis H37Ra infection,” Infection and Immunity, vol. 76, no. 1, pp. 351–360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Molloy, P. Laochumroonvorapong, and G. Kaplan, “Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin,” Journal of Experimental Medicine, vol. 180, no. 4, pp. 1499–1509, 1994. View at Publisher · View at Google Scholar · View at Scopus
  47. M. F. Rodrigues, M. M. Barsante, C. C. S. Alves et al., “Apoptosis of macrophages during pulmonary Mycobacterium bovis infection: correlation with intracellular bacillary load and cytokine levels,” Immunology, vol. 128, no. 1, pp. e691–e699, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Chávez-Galán, L. A. Ramon-Luing, L. Torre-Bouscoulet, R. Pérez-Padilla, and I. Sada-Ovalle, “Pre-exposure of Mycobacterium tuberculosis-infected macrophages to crystalline silica impairs control of bacterial growth by deregulating the balance between apoptosis and necrosis,” PLoS ONE, vol. 8, no. 11, Article ID e80971, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. M. K. Balcewicz-Sablinska, J. Keane, H. Kornfeld, and H. G. Remold, “Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-α,” Journal of Immunology, vol. 161, no. 5, pp. 2636–2641, 1998. View at Google Scholar · View at Scopus
  50. N. Reiling, D. Schneider, and S. Ehlers, “Mycobacterium tuberculosis-induced cell death of primary human monocytes and macrophages is not significantly modulated by tumor necrosis factor-targeted biologicals,” Journal of Investigative Dermatology Symposium Proceedings, vol. 12, no. 1, pp. 26–33, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Dorhoi, G. Nouailles, S. Jörg et al., “Activation of the NLRP3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis,” European Journal of Immunology, vol. 42, no. 2, pp. 374–384, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Novikov, M. Cardone, R. Thompson et al., “Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages,” Journal of Immunology, vol. 187, no. 5, pp. 2540–2547, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Hussain, A. Ansari, N. Talat, Z. Hasan, and G. Dawood, “CCL2/MCP-I genotype-phenotype relationship in latent tuberculosis infection,” PLoS ONE, vol. 6, no. 10, Article ID e25803, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Cai, S. Batra, S. A. Lira, J. K. Kolls, and S. Jeyaseelan, “CXCL1 regulates pulmonary host defense to Klebsiella infection via CXCL2, CXCL5, NF-κB, and MAPKs,” Journal of Immunology, vol. 185, no. 10, pp. 6214–6225, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. N. I. Dmitrieva and M. B. Burg, “Analysis of DNA breaks, DNA damage response, and apoptosis produced by high NaCl,” American Journal of Physiology—Renal Physiology, vol. 295, no. 6, pp. F1678–F1688, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. P. Brousseau, J. Pellerin, Y. Morin et al., “Flow cytometry as a tool to monitor the disturbance of phagocytosis in the clam Mya arenaria hemocytes following in vitro exposure to heavy metals,” Toxicology, vol. 142, no. 2, pp. 145–156, 1999. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Pfister, W. Kerkeni, J. Rigaud et al., “Efficacy and tolerance of one-third full dose bacillus Calmette-Guérin maintenance therapy every 3 months or 6 months: two-year results of URO-BCG-4 multicenter study,” International Journal of Urology, vol. 22, no. 1, pp. 53–60, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Yokomizo, Y. Kanimoto, T. Okamura et al., “Randomized controlled study of the efficacy, safety and quality of life with low dose bacillus Calmette-Guérin instillation therapy for nonmuscle invasive bladder cancer,” Journal of Urology, vol. 195, no. 1, pp. 41–46, 2016. View at Publisher · View at Google Scholar · View at Scopus
  59. D. L. Faustman, The Value of BCG and TNF in Autoimmunity, Elsevier, Academic Press, 1st edition, 2014.